Active ascertainment of recurrence rate after treatment of primary basal cell carcinoma (BCC)

Alam, Murad; Desai, Shraddha; Nodzenski, Michael; Dubina, Meghan; Kim, Natalie; Martini, Mary C.; Fife, Douglas; Reid, Duncan; Pirigyi, Megan; Poon, Emily; Hsu, Jeffrey T.S.; Bhatia, Ashish C.

doi:10.1016/j.jaad.2015.04.036

Cited by 12 publications

(11 citation statements)

References 5 publications

(2 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is in comparison to recurrence frequencies between 12% and 51% demonstrated in older studies that did not employ the use of histographic-controlled Mohs surgery (Borel, 1973;Schuller et al, 1979). Of note, the recurrence rate of BSC is still significantly higher than that of BCC (0.64%) and SCC (1.2%) after Mohs surgery (Alam et al, 2015;Belkin and Carucci, 2011).…”

Section: Discussion Of Incorrect Answersmentioning

confidence: 54%

Cells to Surgery Quiz: December 2019

Williams

Rajabi‐Estarabadi

Long

et al. 2019

Journal of Investigative Dermatology

View full text Add to dashboard Cite

Section: Discussion Of Incorrect Answersmentioning

confidence: 54%

Cells to Surgery Quiz: December 2019

Williams

Rajabi‐Estarabadi

Long

et al. 2019

Journal of Investigative Dermatology

View full text Add to dashboard Cite

“… 10 Recent reports indicate a recurrence rate of 1.1% per patient diagnosed with BCC after surgical removal by Mohs micrographic surgery. 11 …”

Section: Discussionmentioning

confidence: 99%

Superficial basal cell carcinoma treated with 70% trichloroacetic acid applied topically: a case study

Chiriac¹,

Brzeziński²,

Moldovan³

et al. 2017

CCID

View full text Add to dashboard Cite

BackgroundBasal cell carcinoma (BCC) is the most common form of skin cancer, affecting millions of people worldwide. The treatment concept for BCCs is the surgical one, but it is costly, as such, searching for alternative medical therapeutics is justified.AimTo highlight the efficacy of high concentration (70%) trichloroacetic acid (TCA) as a choice therapy for low-risk BCC.Method and patientAuthors present, for the first time, the use of a high concentration TCA applied once a week for 2 consecutive weeks with a toothpick, on a patient with BCC on the right preauricular area.ResultsOn examination 4 weeks later, the lesion was not clinically and dermatoscopically evidenced.ConclusionHigh concentration TCA could be an effective and safe, non-invasive choice of therapy for low-risk BCC, easy to perform, not expensive, with good cosmetic results, especially for patients who are not likely to undergo invasive or expensive treatments.

show abstract

“…According to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology, BSC is included in the high-risk BCC category (2). This is due to the higher metastatic rate when compared with conventional BCC (5-8.4 vs. <0.1%) (6). These metastases occur especially in regional lymph nodes and lungs (7).…”

Section: Introductionmentioning

confidence: 99%

Basal cell carcinoma‑not always the ‘good guy’: Case report of a life‑threatening basosquamous carcinoma and review of the literature

et al. 2021

View full text Add to dashboard Cite

Cutaneous basosquamous carcinoma is a variant of basal cell carcinoma that is characterized by histopathological features of both basal and squamous cell carcinoma. Due to its local invasiveness, high frequency of recurrence, and its metastatic potential, it is considered to be one of the most aggressive subtypes of basal cell carcinoma. We present the case of an 81-year-old male who was admitted to the hospital with incessant hemorrhage arising from a cutaneous tumor that later proved to be a basosquamous carcinoma. Due to the COVID-19 pandemic at the time, the patient did not seek medical attention as soon as the bleeding was observed, although he did present when the symptom increased in intensity and became incessant. To our knowledge, this is the first case report of a cutaneous basosquamous carcinoma that presents with a massive life-threatening hemorrhage tumor, thus endangering the patient's life. The clinical and histopathological features, the behavior and the treatment of cutaneous basosquamous carcinoma are further reviewed in this article.

show abstract

Active ascertainment of recurrence rate after treatment of primary basal cell carcinoma (BCC)

Cited by 12 publications

References 5 publications

Cells to Surgery Quiz: December 2019

Cells to Surgery Quiz: December 2019

Superficial basal cell carcinoma treated with 70% trichloroacetic acid applied topically: a case study

Basal cell carcinoma‑not always the ‘good guy’: Case report of a life‑threatening basosquamous carcinoma and review of the literature

Contact Info

Product

Resources

About